Medtronic's Infuse Bone Graft is once again the center of a lawsuit, according to an Injury Lawyer News report.
Spinal Tech
K2M insider John P. Kostuik, MD, sold 46,957 shares of the company's stock in a transaction on June 18, according to a Mideast Times report.
Histogenics appointed Jonathan Lieber as CFO, effective July 2.
Stryker shares have increased by 1.26 percent in the past week and risen by 0.46 percent for the last four weeks.
The Joint Commission grants Bioness accreditation and the Gold Seal of Approval for healthcare quality and safety for complying with its performance standards. The Gold Seal of Approval affirms Bioness' commitment to quality care to its customers, employees and the…
The U.S. House of Representatives has voted to repeal the medical device tax, according to a report by The Washington Times.
Here are 18 key notes on orthopedic and spine device companies over the past week.
Blue Belt Technologies has partnered with SurgCenter Development.
Orthofix is a global medical device company aiming to develop and deliver repair and regenerative solutions to the spine and orthopedics market. Two investment analysts have rated Orthofix stock a "strong buy" rating.
Hill-Rom bought Welch Allyn for $2.05 billion, resulting in financial benefits for both medical device and technology companies, according to Syracuse Media Group.
